Cargando…

Next Generation of Cancer Drug Repurposing: Therapeutic Combination of Aspirin and Oseltamivir Phosphate Potentiates Gemcitabine to Disable Key Survival Pathways Critical for Pancreatic Cancer Progression

SIMPLE SUMMARY: Drug repurposing in combination with clinical standard chemotherapeutics opens a novel and promising clinical treatment approach for patients with pancreatic cancer. This report presents a novel therapeutic effect of the combination of aspirin and oseltamivir phosphate with chemother...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qorri, Bessi, Mokhtari, Reza Bayat, Harless, William W., Szewczuk, Myron R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946854/ https://www.ncbi.nlm.nih.gov/pubmed/35326525 http://dx.doi.org/10.3390/cancers14061374

Ejemplares similares

Repositioning of Old Drugs for Novel Cancer Therapies: Continuous Therapeutic Perfusion of Aspirin and Oseltamivir Phosphate with Gemcitabine Treatment Disables Tumor Progression, Chemoresistance, and Metastases
por: Qorri, Bessi, et al.
Publicado: (2022)

Novel Molecular Mechanism of Aspirin and Celecoxib Targeting Mammalian Neuraminidase-1 Impedes Epidermal Growth Factor Receptor Signaling Axis and Induces Apoptosis in Pancreatic Cancer Cells
por: Qorri, Bessi, et al.
Publicado: (2020)

A Triple Combination of Metformin, Acetylsalicylic Acid, and Oseltamivir Phosphate Impacts Tumour Spheroid Viability and Upends Chemoresistance in Triple-Negative Breast Cancer
por: Sambi, Manpreet, et al.
Publicado: (2020)

Novel Therapeutic Target Critical for SARS-CoV-2 Infectivity and Induction of the Cytokine Release Syndrome
por: Harless, William W., et al.
Publicado: (2023)

The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy
por: Mokhtari, Reza Bayat, et al.
Publicado: (2021)

Combinatorial and sequential delivery of gemcitabine and oseltamivir phosphate from implantable poly(d,l-lactic-co-glycolic acid) cylinders disables human pancreatic cancer cell survival
por: Allison Logan, Stephanie, et al.
Publicado: (2017)

Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
por: Mokhtari, Reza Bayat, et al.
Publicado: (2021)

Alternative therapies for metastatic breast cancer: multimodal approach targeting tumor cell heterogeneity
por: Sambi, Manpreet, et al.
Publicado: (2017)

Correction: Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis
por: Mokhtari, Reza Bayat, et al.
Publicado: (2022)

The crucial role of primary care providers in the long-term follow-up of adult survivors of childhood cancer
por: Jain, Justin, et al.
Publicado: (2019)

Oseltamivir phosphate released from injectable Pickering emulsions over an extended term disables human pancreatic cancer cell survival
por: Wood, Kurt, et al.
Publicado: (2018)

Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance
por: O’Shea, Leah K, et al.
Publicado: (2014)

Recent advances in “smart” delivery systems for extended drug release in cancer therapy
por: Kalaydina, Regina-Veronicka, et al.
Publicado: (2018)

3D Multicellular Stem-Like Human Breast Tumor Spheroids Enhance Tumorigenicity of Orthotopic Xenografts in Athymic Nude Rat Model
por: Mokhtari, Reza Bayat, et al.
Publicado: (2021)

Non-Nutritive Sweeteners and Their Implications on the Development of Metabolic Syndrome
por: Liauchonak, Iryna, et al.
Publicado: (2019)

Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes Extracellular Matrix Remodeling
por: Qorri, Bessi, et al.
Publicado: (2018)

Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma
por: Haxho, Fiona, et al.
Publicado: (2014)

Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
por: Mouhamed, Yara, et al.
Publicado: (2018)

Therapeutic designed poly (lactic-co-glycolic acid) cylindrical oseltamivir phosphate-loaded implants impede tumor neovascularization, growth and metastasis in mouse model of human pancreatic carcinoma
por: Hrynyk, Michael, et al.
Publicado: (2015)

The Biased G-Protein-Coupled Receptor Agonism Bridges the Gap between the Insulin Receptor and the Metabolic Syndrome
por: Liauchonak, Iryna, et al.
Publicado: (2018)

Next-Generation Multimodality of Nanomedicine Therapy: Size and Structure Dependence of Folic Acid Conjugated Copolymers Actively Target Cancer Cells in Disabling Cell Division and Inducing Apoptosis
por: Sambi, Manpreet, et al.
Publicado: (2019)

Oseltamivir Carboxylate, the Active Metabolite of Oseltamivir Phosphate (Tamiflu), Detected in Sewage Discharge and River Water in Japan
por: Ghosh, Gopal C., et al.
Publicado: (2010)

Aspirin at 120: Retiring, recombining, or repurposing?
por: Patrono, Carlo, et al.
Publicado: (2021)

Aspirin counteracts cancer stem cell features, desmoplasia and gemcitabine resistance in pancreatic cancer
por: Zhang, Yiyao, et al.
Publicado: (2015)

Anti-Influenza Neuraminidase Inhibitor Oseltamivir Phosphate Induces Canine Mammary Cancer Cell Aggressiveness
por: de Oliveira, Joana T., et al.
Publicado: (2015)

Aspirin Repurposing in Folate-Decorated Nanoparticles: Another Way to Target Breast Cancer
por: Kanwal, Fariha, et al.
Publicado: (2022)

Aspirin for the next generation
por: Henderson, Nick, et al.
Publicado: (2013)

The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer
por: Florio, Rosalba, et al.
Publicado: (2019)

Development of High Dose Oseltamivir Phosphate Dry Powder for Inhalation Therapy in Viral Pneumonia
por: Aziz, Shahir, et al.
Publicado: (2020)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
por: Jang, Kyungho, et al.
Publicado: (2017)

The Hippo Pathway Effectors YAP/TAZ-TEAD Oncoproteins as Emerging Therapeutic Targets in the Tumor Microenvironment
por: Mokhtari, Reza Bayat, et al.
Publicado: (2023)

Repurposing antitussive benproperine phosphate against pancreatic cancer depends on autophagy arrest
por: Zhang, Huanyu, et al.
Publicado: (2020)

A physiologically-based pharmacokinetic model of oseltamivir phosphate and its carboxylate metabolite for rats and humans
por: Gao, Guanghua, et al.
Publicado: (2019)

Potential of antiviral drug oseltamivir for the treatment of liver cancer
por: Huang, Pei-Ju, et al.
Publicado: (2021)

Population pharmacokinetics of oseltamivir and oseltamivir carboxylate in obese and non‐obese volunteers
por: Chairat, Kalayanee, et al.
Publicado: (2016)

Oseltamivir dosing with haemofiltration
por: Tomlin, M, et al.
Publicado: (2010)

Chemical Analysis and Transplacental Transfer of Oseltamivir and Oseltamivir Carboxylic Acid in Pregnant Rats
por: Lin, Chia-Chun, et al.
Publicado: (2012)

Efficacy of Combination Therapy with Oseltamivir Phosphate and Azithromycin for Influenza: A Multicenter, Open-Label, Randomized Study
por: Kakeya, Hiroshi, et al.
Publicado: (2014)

Kinetic Study of the Alkaline Degradation of Oseltamivir Phosphate and Valacyclovir Hydrochloride using Validated Stability Indicating HPLC
por: Al-Bagary, Ramzia I, et al.
Publicado: (2014)

Oseltamivir phosphate for suspension is bioequivalent to TAMIFLU in healthy volunteers: a randomized, open-label clinical study
por: Wang, Ying, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f9fvce605c53ogptfuvo94ti24